Category: Global Regulation

  • Taiwan: HTPs Given Conditional Approval, Blocked For Personal Import

    Taiwan: HTPs Given Conditional Approval, Blocked For Personal Import

    Taiwan’s Health Promotion Administration has conditionally approved 14 heated tobacco products for legal sale under the revised Tobacco Hazards Prevention Act, the agency announced Tuesday. Customs confirms that personal imports of heated tobacco products (HTPs) remain prohibited.

    Lo Shu-ying, head of the HPA’s Tobacco Control Division, said the approval process will follow the same procedures used for traditional tobacco products, including a review of packaging and product contents.

    Lo added that the HPA will work with the Customs Administration and the Ministry of Finance to discuss supporting measures, such as the import of heated tobacco products by individuals and the collection of tobacco surcharges, but only after the current administrative reviews are completed.

  • New Zealand: PMI Tax Incentive Extended Through 2027

    New Zealand: PMI Tax Incentive Extended Through 2027

    New Zealand’s tax incentive for Heated Tobacco Products, initially introduced in mid-2024 as a one-year pilot, has been extended for two additional years, with the formal review now moved to July 2027. The excise tax was halved in a bid to encourage smokers to switch from combustible cigarettes to less harmful alternatives.

    The initial trial failed to generate viable data: health ministry briefings confirmed that Philip Morris did not pass cost savings to consumers in the critical early phase, and IQOS devices were removed from shelves for approximately five months due to non‑compliance with battery-removability regulations. Officials described any evaluation at that point as “meaningless,” given that reduced priced HTPs were unavailable for the majority of the trial period.

    Associate Health Minister Casey Costello justified the extension by citing her own “independent advice,” later revealed to consist of five articles—many outdated or about different products—that offered only marginal support for HTP-friendly tax policy. Treasury officials warned that Philip Morris, as the sole importer, would reap the bulk of the estimated NZ$200–300 million cost over the extended term.

    Opposition health advocates suggest the extension favors multinational manufacturers—particularly Philip Morris, which dominates New Zealand’s HTP market—and question whether it undermines broader tobacco control efforts. Government officials maintain that lifting the removable battery requirement for IQOS was a necessary compliance fix and that further data is essential to assess whether price reductions have prompted meaningful user transitions away from conventional cigarettes.

    Cabinet and Costello’s office emphasized the need for more robust market data before concluding the HTP pilot. The extended evaluation, now slated for 2027, will not only assess smoker uptake but also unintended demographic use—particularly young people—and any substitution away from vaping or cigarettes. Simultaneously, documents released from JUUL litigation revealed lobbying initiatives targeting NZ First, alleging PMI had pitched draft regulations to align with its interests. While party leaders deny wrongdoing, critics highlight the decision as symptomatic of “highly industry-friendly” policymaking.

  • Minnesota Mandates “Mental Health Warning” Labels on Social Platforms

    Minnesota Mandates “Mental Health Warning” Labels on Social Platforms

    Minnesota lawmakers have enacted what’s believed to be the nation’s first statutory requirement for social media platforms to display a conspicuous mental health warning at every login. Under HF 1289, effective July 1, 2026, platforms must show a pop-up label warning of risks such as anxiety, depression, addiction and cyberbullying, and must include crisis hotline information like the 988 Lifeline. The label stays onscreen until the user either acknowledges it or exits the app; it may not be bypassed or hidden within fine print. Health commissioners must issue implementation guidelines by March 1, 2026.

    Supporters argue the policy fills a regulatory gap in public health communications, drawing parallels to tobacco warning labels. Critics warn it may raise free-speech concerns and pose enforcement challenges, especially given the global footprint of leading social media platforms.

  • Indonesian Academic Calls for Annual 25% Minimum Tax Increase

    Indonesian Academic Calls for Annual 25% Minimum Tax Increase

    A leading academic voice from the University of Indonesia’s Center for Social Security Studies (PKJS UI) is calling for a 25% annual increase in Indonesia’s minimum tobacco tax, citing affordability and rising youth smoking rates as critical public health concerns. Speaking at a media workshop on tobacco control, PKJS UI Head Aryana Satrya argued that Indonesia’s cigarette prices — despite reaching Rp 49,900 ($3 USD) — remain among the lowest globally, enabling widespread access, especially among minors.

    Citing internal research, Satrya claimed that raising prices to Rp 60,000–70,000 could compel 60–70% of smokers to quit. The call for tax hikes is tied to a broader push for stricter allocation of tobacco tax revenue toward cessation services, public health education, enforcement of smoke-free areas, and anti-illicit trade initiatives. PKJS UI recommends mandating that at least 40% of shared tobacco tax revenues (DBH CHT) and 25% of regional cigarette taxes (PRD) directly fund tobacco control programs.

    Meanwhile, government officials reaffirmed that Rp 6.39 trillion in DBH CHT will be distributed across 27 provinces in 2025, with health receiving 40% of that allocation. However, pressure is mounting to direct a larger and more consistent share toward demand-reduction strategies.

    Data from the 2023 Indonesian Health Survey shows that the country now has 63.1 million active smokers, including a troubling 7.4% of youth aged 10–18. Even more alarming is the emergence of smoking behavior among children aged as young as 4, with 2.6% of child smokers falling into the 4–9 age group.

  • Vietnam to Hike Tobacco Taxes Under New Law

    Vietnam to Hike Tobacco Taxes Under New Law

    Vietnam’s National Assembly passed a new law significantly raising the Special Consumption Tax on tobacco, alcohol, and beer starting January 1, 2026. The law introduces a tax roadmap for tobacco products from 2027 to 2031, adding absolute tax amounts on top of existing percentage-based taxes for the first time.

    Under the new plan:

    • Cigarettes: Tax increases by VND 2,000 ($0.08) per pack annually, reaching VND 10,000 ($0.40) per pack by 2031.
    • Cigars: Starting at VND 20,000 ($0.80) per cigar in 2027, rising to VND 100,000 ($4) per cigar in 2031.
    • Other tobacco forms (e.g., pipe or shredded tobacco): Set at VND 20,000/100g or 100ml in 2027, increasing to VND 100,000 by 2031.

    This is the first time Vietnam will implement a structured absolute tobacco tax, following the lead of other countries around the globe. Prior to this, only ad valorem taxes applied.

  • Namibia Considering Alcohol and Tobacco Tax Hikes

    Namibia Considering Alcohol and Tobacco Tax Hikes

    The Namibian government is exploring new tax reforms on tobacco and alcohol products as part of broader efforts to combat substance abuse and improve public health outcomes, Minister of Health and Social Services Esperance Luvindao announced this week. Speaking at the opening of a four-day workshop on tobacco and alcohol policy, Luvindao emphasized the growing burden of tobacco and alcohol use on the country’s healthcare system, calling for “further deterrent actions,” particularly increased taxation, to reduce consumption.

    Namibia is aligning its strategy with the World Health Organization’s MPOWER policy package, which includes raising taxes, offering cessation support, and strengthening regulations. The country enacted the Tobacco Product Control Act in 2010, with supporting regulations in 2014, and is now reviewing it to address emerging nicotine products such as vapes, e-cigarettes, and hookah.

  • 1 in 5 Dutch Stores Violated Tobacco Sales Ban

    1 in 5 Dutch Stores Violated Tobacco Sales Ban

    Nearly 21% of supermarkets and convenience stores violated the Netherlands’ tobacco and vape sales ban in its first six months, according to the Netherlands Food and Consumer Product Authority (NVWA). The ban, in effect since July 1, 2024, prohibits the sale of tobacco products in supermarkets, hospitality venues, and online. Smaller stores showed the lowest compliance rates.

    State Secretary Judith Tielen plans to increase fines and give NVWA stronger enforcement powers, including enhanced inspections and product seizures.

    “Every violation is one too many,” said Tielen, who also urged schools and parents to help prevent youth access to vapes. “We will, of course, do what we can to improve, but there are legal challenges and the legislative process takes a very long time.”

  • Pakistan Empowers Provincial Officials to Seize Illicit Cigarettes

    Pakistan Empowers Provincial Officials to Seize Illicit Cigarettes

    Pakistan’s Federal Board of Revenue (FBR) authorized provincial officials—including deputy commissioners, assistant commissioners, and excise officers—to raid and seize smuggled or tax-evading cigarettes at retail outlets, warehouses, and in transit. Under the order, provincial officers can now target counterfeit or untaxed cigarettes and their transport vehicles. All seized goods will be handed over to the nearest Regional Tax Office for further legal action.

    Seized cigarettes lacking valid tax stamps, or with fake ones, will be confiscated and destroyed, with seizures reported to the FBR within 48 hours using a newly developed application. The move is aimed at curbing illicit cigarette trade and ensuring compliance with excise regulations across Pakistan.

  • Minneapolis Sets $25 Minimum on Vapes in Landmark Ordinance

    Minneapolis Sets $25 Minimum on Vapes in Landmark Ordinance

    The Minneapolis City Council unanimously passed a new ordinance establishing a minimum price of $25 for all vaping devices, making it the first known law of its kind in the U.S. Approved at the council’s July 10 meeting, the law is expected to take effect soon, with Mayor Jacob Frey signaling his support.

    The new rule extends the city’s existing tobacco pricing policies and is aimed squarely at curbing youth access to “cheap disposable vapes.” The ordinance applies to any type of electronic delivery device, regardless of whether it contains e-liquid, but excludes e-liquid bottles, prefilled pods, and accessories. Retailers must now price each vape device at no less than $25 before taxes or fees, even if sold in multipacks.

    While public health advocates support the measure, local retailers may face sales losses as customers travel outside the city to avoid higher prices.

    Minneapolis already has minimum prices on cigarettes and other tobacco products.

  • FDA Embraces “Radical Transparency” by Publishing CRLs

    FDA Embraces “Radical Transparency” by Publishing CRLs

    On July 10, the U.S. Food and Drug Administration (FDA) published more than 200 decision letters, known as complete response letters (CRLs). The CRLs were issued in response to applications submitted to the FDA for approval of drugs or biological products between 2020 and 2024, marking a significant step in the Agency’s broader initiatives to modernize and increase transparency.

    By making the CRLs available, the public now has significantly greater insight into the FDA’s decision-making and the most common deficiencies cited that sponsors must address before their application is approved.

    “For far too long, drug developers have been playing a guessing game when navigating the FDA,” said FDA Commissioner Marty Makary. “Drug developers and capital markets alike want predictability. So today we’re one step closer to delivering it to them, with an ultimate goal of bringing cures and meaningful treatments to patients faster.”

    “Because the FDA has historically refrained from publishing CRLs for pending applications, sponsors often misrepresent the rationale behind FDA’s decision to their stakeholders and the public,” the press release said. “According to a 2015 analysis conducted by FDA researchers, sponsors avoided mentioning 85% of the FDA’s concerns about safety and efficacy when announcing publicly that their application was not approved. Moreover, when FDA calls for a new clinical trial for safety or efficacy, that critical information is not disclosed approximately 40% of the time. Lessons learned from non-approvals are also not shared within the industry, leading companies to repeatedly make similar mistakes.”

    This initial batch of published decision letters associated with since-approved applications is now accessible to the public at openFDA. The Agency is in the process of publishing additional CRLs from its archives and is continuously exploring ways of providing the public with greater transparency into its decision-making process.

    On the surface, this all sounds like good news for companies that have spent years frustrated by FDA backlogs. What actually changes remains to be seen.

    “Commissioner Makary’s announcement raises questions about whether this effort is truly ‘radical transparency’ or just a repackaging of existing requirements,” Sarah Wicks and Michelle L. Butler wrote for FDA Law Blog. “The key difference may lie in timing and ease of access; despite the statutory requirement under FDAAA, action packages are often slow to appear on FDA’s website, especially following staffing disruptions at FDA.

    “It is currently unclear whether FDA intends to publish CRLs close in time to their issuance or for applications that are not subsequently approved. The prospect of publication of such CRLs would likely be of great concern to many applicants and of great interest to their competitors. Regardless, we will be watching to see how this radical transparency initiative unfolds.”